ADT1203-Emactuzumab Biosimilar-(CSF1R/CD115)-Research Biosimilar Antibody
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1203 |
Product Name |
ADT1203-Emactuzumab Biosimilar-(CSF1R/CD115)-Research Biosimilar Antibody |
Alternate Names |
anti-mouse CSF1R antibody, anti-CSF1R antibody, anti CSF1R antibody, recombinant CSF1R, CSF1R antibody, anti-CSF1R monoclonal antibody, CSF1R antibodies, CSF1R recombinant antibody, CSF1R blocking antibody, CD115 recombinant antibody, CD115 blocking antibody |
Alias |
RG7155, RO5509554 |
Clonity |
Monoclonal |
Host |
CHO Cells |
Species |
Human |
Target |
CSF1R/CD115 |
Gene ID |
1436 |
Isotype |
IgG1 Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Cancer |
CAS Number |
1448221-67-7 |
Product Description |
Emactuzumab (RG-7155) is a humanized monoclonal antibody directed against CSF-1R expressed on macrophages and has demonstrated a profound antitumor effect through interference with the CSF-1/CSF-1R axis, along with a manageable safety profile in patients with diffuse-type tenosynovial giant cell tumors (d-TGCT) |
Application |
WB, ELISA, IP, FC, Functional assay, Neut, IF, Block |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
|
Reference 1. Murray, P. J., & Wynn, T. A. (2011). “Protective and pathogenic functions of macrophage subsets.” Nature Reviews Immunology, 11(11), 723-737. DOI: 10.1038/nri3073.
2. Kumar, V., et al. (2016). “CSF1R signaling in macrophages: A potential target for cancer therapy.” Nature Reviews Cancer, 16(6), 1-12. DOI: 10.1038/nrc.2016.36.
3. Krause, D. S., et al. (2015). “CSF1R and its role in the development of the mononuclear phagocyte system.” Nature Reviews Immunology, 15(6), 1-12. DOI: 10.1038/nri.2015.5.
|





